MedTrace Logo

Assessment of EyeArt Performance With Retinal Imaging Devices

NCT04302012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2021-07-08

No results posted yet for this study

Summary

The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using multiple retinal imaging devices and operators.

Conditions

Interventions

PROCEDURE

Color fundus photography

Subjects will undergo fundus photography before and/or after administration of mydriatic agent

DRUG

Mydriatic Agent

Subjects may be administered mydriatic medication to dilate their pupils.

Sponsors & Collaborators

  • Eyenuk, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2020-02-27
Completion
2020-02-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04302012 on ClinicalTrials.gov